[
  {
    "ts": "2025-12-11T11:59:00+00:00",
    "headline": "U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma",
    "summary": "PRINCETON, N.J., December 11, 2025--US FDA Grants Priority Review to Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Chemotherapy Combination for Classic Hodgkin Lymphoma",
    "url": "https://finance.yahoo.com/news/u-food-drug-administration-fda-115900732.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "88cc6ed4-d196-34f9-9995-f6210b1030a3",
      "content": {
        "id": "88cc6ed4-d196-34f9-9995-f6210b1030a3",
        "contentType": "STORY",
        "title": "U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma",
        "description": "",
        "summary": "PRINCETON, N.J., December 11, 2025--US FDA Grants Priority Review to Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Chemotherapy Combination for Classic Hodgkin Lymphoma",
        "pubDate": "2025-12-11T11:59:00Z",
        "displayTime": "2025-12-11T11:59:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/7df2d92dd0eefd370d0baf701e3c9671",
          "originalWidth": 1497,
          "originalHeight": 206,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EwyS5K4VWpLnsNZ453ZJ2g--~B/aD0yMDY7dz0xNDk3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/7df2d92dd0eefd370d0baf701e3c9671.cf.webp",
              "width": 1497,
              "height": 206,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/__efceiZ8DBsK6Sn60m.ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7df2d92dd0eefd370d0baf701e3c9671.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/u-food-drug-administration-fda-115900732.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/u-food-drug-administration-fda-115900732.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-11T04:36:06+00:00",
    "headline": "3 Unpopular Stocks with Questionable Fundamentals",
    "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
    "url": "https://finance.yahoo.com/news/3-unpopular-stocks-questionable-fundamentals-043606875.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "ad9dddbf-e80c-37f1-a078-5e4a220ba4c6",
      "content": {
        "id": "ad9dddbf-e80c-37f1-a078-5e4a220ba4c6",
        "contentType": "STORY",
        "title": "3 Unpopular Stocks with Questionable Fundamentals",
        "description": "",
        "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
        "pubDate": "2025-12-11T04:36:06Z",
        "displayTime": "2025-12-11T04:36:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/bd01267adc63bb5f45458f264cb3d6a2",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CROX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DJFhQ1MfArNnd1Gtx6.TRw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/bd01267adc63bb5f45458f264cb3d6a2.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7ai0GlUxYTJUgFj.XF25nQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/bd01267adc63bb5f45458f264cb3d6a2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-unpopular-stocks-questionable-fundamentals-043606875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-unpopular-stocks-questionable-fundamentals-043606875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BFH"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CROX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]